Status:
COMPLETED
Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice
Lead Sponsor:
Pfizer
Conditions:
Osteoporosis
Eligibility:
FEMALE
Brief Summary
This survey is conducted for preparing application material for re examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, and assessing the safety and efficacy profiles of V...
Detailed Description
continuous enrollment
Eligibility Criteria
Inclusion
- Postmenopausal osteoporosis and osteopenia patients
Exclusion
- Patients with active or past history of venous thromboembolic events including deep vein thrombosis,
- Patients with pulmonary embolism and retinal vein thrombosis
Key Trial Info
Start Date :
October 24 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2017
Estimated Enrollment :
3430 Patients enrolled
Trial Details
Trial ID
NCT01793142
Start Date
October 24 2013
End Date
May 31 2017
Last Update
December 24 2018
Active Locations (60)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University Haeundae Paik Hospital
Haeundae-gu, Busan, South Korea, 48108
2
The Catholic University of Korea, Seoul St.Mary's Hospital
Seoul, Capital Metropolitan, South Korea, 06591
3
Dankook University Hospital
Cheonan-si, Chuncheongnam-do, South Korea, 31116
4
Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea, 26426